Unfavorable treatment outcomes among patients with drug-resistant TB in Uganda
The International Journal of Tuberculosis and Lung Disease · 01.04.2023 · 27 (4) · 291-297
DOI: 10.5588/ijtld.22.0638 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 01.04.2023. Verfasst von T M Kintu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Gefördert von: FIC NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Drug-resistant TB (DR-TB) remains a significant public health burden and a threat to the progress made in TB control and prevention in sub-Saharan Africa. OBJECTIVE: To determine the risk-predictors of poor treatment outcomes in patients with DR-TB in Uganda. METHODS: We retrospectively reviewed medical records of adult Ugandans who had been treated for DR-TB at Mbarara Regional Referral Hospital (MRRH) in Uganda. RESULTS: Of the 385 files reviewed, 332 (86.2%) met the study inclusion criteria. Of these, 226 (68.1%) were men and 193 (58.1%) were HIV-positive. A total of 73 participants (22.7%) had unfavorable treatment outcomes (treatment failure, loss to follow-up or death). History of cigarette smoking (OR 5.10, 95% CI 2.4–11.4; P < 0.001), age >60 years (OR 6.32, 95% CI 2.2–18.6; P < 0.001), anemia (OR 2.38, 95% CI 1.1–5.3; P = 0.02) and thrombocytopenia (OR 3.60, 95% CI 1.6–8.1; P < 0.001) were independent predictors of unfavorable treatment outcomes. CONCLUSION: There is a high prevalence of unfavorable treatment outcomes among patients with DR-TB. Further research is required to design a prognostic model for DR-TB patients in a resource-limited setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
- Tuberculosis Treatment Unit, Mbarara Regional Referral Hospital, Mbarara, Uganda.
- Division of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.
- Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda, Tuberculosis Treatment Unit, Mbarara Regional Referral Hospital, Mbarara, Uganda, Department of Medicine, Division of Infectious Dis…
Förderung
- FIC NIH HHS
Zitieren
APA
Kintu, T. M., Mwanahamisi, B. S., Muwanguzi, M., Kyagambiddwa, T., Miiro, E., Tishekwa, N., Lodiong, L. J. D., Timbiine, A. K., Tumukunde, P., Baluku, J. B., & Nuwagira, E. (2023). Unfavorable treatment outcomes among patients with drug-resistant TB in Uganda. The International Journal of Tuberculosis and Lung Disease, 27(4), 291-297. https://doi.org/10.5588/ijtld.22.0638
Vancouver
Kintu TM, Mwanahamisi BS, Muwanguzi M, Kyagambiddwa T, Miiro E, Tishekwa N, et al. Unfavorable treatment outcomes among patients with drug-resistant TB in Uganda. The International Journal of Tuberculosis and Lung Disease. 2023;27(4):291-297. doi:10.5588/ijtld.22.0638
BibTeX
@article{Kintu2023,
author = {Kintu, T M and Mwanahamisi, B S and Muwanguzi, M and Kyagambiddwa, T and Miiro, E and Tishekwa, N and Lodiong, L J D and Timbiine, A K and Tumukunde, P and Baluku, J B and Nuwagira, E},
title = {Unfavorable treatment outcomes among patients with drug-resistant TB in Uganda},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2023},
volume = {27},
number = {4},
pages = {291--297},
doi = {10.5588/ijtld.22.0638}
}
EUVIMED